skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

48 Total results for product and free and sample content found

Trialtrove

The Coming of Age of Biosimilars in Autoimmune and Inflammatory Diseases

By Laura Runkel 19 Jun 2017

Biosimilars for autoimmune drugs, including humira, remicade, etanercept, rituximab and others, have been in clinical development for several years.

Topic Biosimilars

Trialtrove

One Size No Longer Fits All: The Personalized Medicine Trial Landscape

By Doro Shin 31 May 2017

One Size No Longer Fits All comes to you from In Vivo, part of the Informa Pharma Intelligence suite of tools. Leveraging a unique array of news, data, analysis, and consulting products and services.

Topic Personalized Medicine

Trialtrove

2016 Completed Clinical Trials: Industry Strategies Revealed and Graded

By Christine Blazynski PhD 30 May 2017

Company pipeline depictions are snapshots that illustrate, at that point in time, where a therapeutic candidate sits in terms of development stage for a specific therapy area or disease.

Trialtrove

First for Fatty Liver – Who will win the race to be the first NAFLD treatment to market?

By Ethan Hebert 19 Apr 2017

Currently there are no approved pharmacological treatments for non-alcoholic fatty liver disease (NAFLD), including the subtype non-alcoholic steatohepatitis (NASH).

Topic Clinical trials

Trialtrove

A Review of the Current Landscape of Renal Anemia Research

01 Apr 2017

Data for this informative report comes from Trialtrove, Pharmaprojects, and Datamonitor Healthcare, all part of the Citeline suite of tools from Pharma Intelligence.

Topic Research

Sitetrove

How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial

By Loni Branon 24 Mar 2017

Enrollment success...This is what we all strive for but unfortunately it does not always happen and there is no money-back guarantee.

Topic Clinical trials

Sitetrove

How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial

By Loni Branon 24 Mar 2017

Enrollment success...This is what we all strive for but unfortunately it does not always happen and there is no money-back guarantee.

Topic Clinical trials

Pharmaprojects, Biomedtracker, Trialtrove

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

By Rachel Meighan-Mantha 22 Mar 2017

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

Topic Cancer Clinical trial optimization

Pharmaprojects

Statins forever: Is anything set to topple this class’s mighty reign?

22 Mar 2017

With the recent controversy surrounding the approval and launch of the first wave of PCSK9 inhibitors (focussing mainly on the extremely high cost in comparison to statin therapies), it may be easy to forget that the dyslipidaemia space has also been plagued by a number of high profile and costly failures too.

Topic Drug development landscape

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: